
Quantitative and qualitative improvement in IOL design

Quantitative and qualitative improvement in IOL design


In court documents in Connecticut Superior Court in Bridgeport, Isidore Sobkowski claims surgeons at the Wilton Surgery Center failed to properly clean their instruments resulting in him contracting a sight-threatening eye infection.

According to the company, NCX 470 is a novel NO-donating bimatoprost eye drop, is currently in Phase 3 clinical development for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.

Wang and colleagues conducted a retrospective case series patients with full-thickness macular holes.

Electrophysiologic testing combined with structural imaging to zero in on issues.

Research estimates that the RVO market with see a compound annual growth rate of 11.9%.

With 37 years of clinical trial experience, Peter J. McDonnell, MD, offer some tips.

NR1D1 and NR2E3 orphan nuclear receptors were found to have low levels of expression in patients with advanced retinoblastoma.

The company noted that individuals can purchase the ARx AI headset and register for access to the Seeing AI app through the provided links or download the latest version of the NaviLens app.

The company’s EVO family of Implantable Collamer Lenses for myopia, astigmatism and presbyopia, are designed to correct vision through a minimally invasive procedure.

The investigators explained that the survival rate of patients with retinoblastoma has improved significantly as a result of intra-arterial chemotherapy and enucleation surgery.


After 3 loading doses, the patients were randomly assigned to receive EYP-1901 or continue to receive aflibercept at an 8-week dosing pattern for 32 weeks.

Viewing the solar eclipse without proper eye protection can pose hazards, and ophthalmologists can educate patients about the importance of using certified solar viewing glasses or other safe viewing methods.

A review of the phase 4 PALADIN data show that steroid-eluting implants lead to good vision, safe outcomes, and reduced burden in patients with DME.


Researchers investigated patients' ability to drive and work following eye injury

New members bring a wealth of experience and expertise from various sectors within the ophthalmology, pharmaceutical, and healthcare fields, further strengthening the Ophthalmology Foundation's mission.

Study findings show every $1 invested in eye care sees $36 in return globally

It is important that the ophthalmic community redouble our efforts in following patients with age-related macular degeneration (AMD) using optical coherence tomography (OCT) to find the early signs of geographic atrophy (GA).

An investigation is set to launch on SpaceX’s 30th Commercial Resupply Services mission to the International Space Station contracted by NASA to test the therapy in space.

Gildeuretinol halts Stargardt disease progression for up to 6 years.

Andrew G. Lee, MD, outlines his stance on whether all patients with idiopathic intracranial hypertension should have a lumbar puncture, emphasizing clinical judgment and treatment strategies.

The International Headache Society has provided criteria for visual snow syndrome (VSS).


A case study emphasises the shifting paradigm in clinical best practices

The benefit concert will be held at 8 pm April 7 at The Sinclair in Cambridge, and will feature performances by ophthalmologists and industry partners.

DMEI provides more than 225,000 total patient visits per year from all 77 Oklahoma counties and the surrounding six-state region through its main location on the University of Oklahoma Health Sciences Center campus in Oklahoma City and four satellite locations.

Observing potential cases highlights the importance of monitoring and reporting, contributing to a comprehensive understanding of therapeutic effects.